Literature DB >> 15224213

Frequency and clinical features of visceral malignancy in a consecutive case series of patients with periocular sebaceous gland carcinoma.

R Max Conway1, Alexander von Moller, Wolfgang Ballhausen, Anselm Jünemann, Leonard M Holbach.   

Abstract

PURPOSE: To report the frequency and clinical features of internal visceral malignancy in an unselected series of patients with sebaceous gland carcinoma (SGC).
METHODS: A non-comparative retrospective case series of consecutive patients with a histologically proven diagnosis of periocular sebaceous cell carcinoma treated at the University Eye Hospital, University of Erlangen-Nürnberg between 1981 and 2000.
RESULTS: Twenty-three patients were identified, each with one tumor. Men and women were almost equally affected with a mean age at diagnosis of 62 years (range 37-83 years). The majority of tumors were located in the upper lid, but five tumors were situated in the lower lid or caruncle. In 22 of the 23 patients the diagnosis at referral was either incorrect or not suspected. In all cases, the SGC was treated by surgical excision. In the systems review, 11 of the 23 patients (48%) had evidence of previous systemic malignancy, the most common being colorectal cancer followed by liver and bronchial carcinoma. Forty-five percent of patients with SGC and internal visceral malignancy eventually died as a result of their tumors.
CONCLUSION: Periocular SGC remains an underdiagnosed entity for which a high level of clinical suspicion is critical for early recognition. Almost half the patients additionally had an internal visceral malignancy. Internal visceral malignancy in unselected patients with SGC may be more common and have a more guarded prognosis than has been appreciated.

Entities:  

Mesh:

Year:  2004        PMID: 15224213     DOI: 10.1007/s00417-003-0856-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  Sebaceous carcinoma of the eyelid: a clinicopathological study.

Authors:  M Zürcher; C R Hintschich; A Garner; C Bunce; J R Collin
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis.

Authors:  J T Wolfe; R P Yeatts; M R Wick; R J Campbell; R R Waller
Journal:  Am J Surg Pathol       Date:  1984-08       Impact factor: 6.394

Review 3.  Clinicopathological relevance of the association between gastrointestinal and sebaceous neoplasms: the Muir-Torre syndrome.

Authors:  F Paraf; D Sasseville; A K Watters; S Narod; O Ginsburg; H Shibata; S Jothy
Journal:  Hum Pathol       Date:  1995-04       Impact factor: 3.466

4.  Sebaceous gland carcinoma. Review of 40 cases.

Authors:  M T Doxanas; W R Green
Journal:  Arch Ophthalmol       Date:  1984-02

5.  Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.

Authors:  Leonard M Holbach; Alexander von Moller; Carsten Decker; Anselm G M Jünemann; Carmen Rummelt-Hofmann; Wolfgang G Ballhausen
Journal:  Am J Ophthalmol       Date:  2002-07       Impact factor: 5.258

Review 6.  The Muir-Torre syndrome: a 25-year retrospect.

Authors:  R A Schwartz; D P Torre
Journal:  J Am Acad Dermatol       Date:  1995-07       Impact factor: 11.527

7.  Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data.

Authors:  N A Rao; A A Hidayat; I W McLean; L E Zimmerman
Journal:  Hum Pathol       Date:  1982-02       Impact factor: 3.466

8.  Sebaceous carcinoma of the periorbital and extraorbital regions.

Authors:  M A Pickford; F J Hogg; M E Fallowfield; M H Webster
Journal:  Br J Plast Surg       Date:  1995-03
  8 in total
  2 in total

1.  [Differential diagnosis and treatment options for conjunctival tumors].

Authors:  L M Holbach; P Pogorelov; F E Kruse
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

2.  Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.

Authors:  Tiina Leivo; Johanna Sarmela; Maria Enckell-Aaltonen; Eva Dafgård Kopp; Caroline Schmitt; Peter B Toft; Haraldur Sigurdsson; Marita Uusitalo
Journal:  BMC Ophthalmol       Date:  2020-03-16       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.